ASP Isotopes Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022
Cash & Equivalents	7.91	2.39
Cash & Cash Equivalents	7.91	2.39
Cash Growth	231.01%	-
Receivables	0.22	0
Other Current Assets	2.39	0.91
Total Current Assets	10.51	3.3
Property, Plant & Equipment	11.97	9.05
Goodwill and Intangibles	3.27	0
Other Long-Term Assets	1.79	0.14
Total Long-Term Assets	17.03	9.19
Total Assets	27.54	12.5
Accounts Payable	1.11	1.35
Deferred Revenue	0.88	0
Current Debt	0.87	0.08
Other Current Liabilities	2.81	0.5
Total Current Liabilities	5.67	1.94
Long-Term Debt	1.27	0.74
Other Long-Term Liabilities	1.76	0
Total Long-Term Liabilities	3.04	0.74
Total Liabilities	8.71	2.68
Total Debt	2.14	0.82
Debt Growth	160.60%	-
Retained Earnings	-23.84	-7.55
Comprehensive Income	-0.92	0.26
Shareholders' Equity	16.3	9.82
Net Cash / Debt	5.77	1.57
Net Cash / Debt Growth	267.95%	-
Net Cash Per Share	0.17	0.06
Working Capital	4.84	1.37
Book Value Per Share	0.49	0.37

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).